Stason Pharmaceuticals has licenced Lonza's GS Gene Expression System to develop and manufacture antibodies for tissue necrosis therapy

Lonza

DSM Pharmaceutical Products has licenced c-LEcta's alcohol dehydrogenates for screening programs and process development

PR Newswire

Aesica expands into Europe

Aesica is to acquire three pharmaceutical manufacturing facilities from UCB. Aesica will acquire facilities in Monheim and Zwickau in Germany and Pianezza in Italy. In addition Aesica has signed a long-term supply agreement to supply UCB's products. 600 employees will be transferred from UCB to Aesica. Aesica believes acquisition of the UCB sites "will support and enable its future growth and evolution". Financial details of the deal, which is expected to close in Q1 2011, were not revealed.
Manufacturing Chemist

India plans to increase the number of manufacturing plant inspectors for local an overseas facilities

Business Standard

Aptuit is to shed 340 jobs at two facilities in Scotland

Scotland on Sunday

Currency changes will hit Lonza profits by CHF30m in 2010

Wall Street Journal

Jubilant Life Sciences has completed the demerger of its performance polymers and aggro businesses into Jubilant Industries

Business Standard

Pfenex will supply a cGMP-grade carrier protein to The Henry M. Jackson Foundation for the Advancement of Military Medicine for vaccine development

Almac has added a dedicated late-stage customisation suite for orphan drugs and niche products to its facilities in Craigavon, UK

SP2

Dottikon confirms first half loss

Dottikon